Stock UniverseDerived research view · source repositories remain read-only

Johnson & Johnson (JNJ)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - General
Score Band
Qualified
Selection Score
38.19
Global Rank
665
Market Cap
598.69B
Latest Close
232.77
RS Composite
-2.58% · G#1560

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
4.22%
3M
-3.17%
6M
13.97%
1Y
54.82%
3Y
62.92%
5Y
57.39%
10Y
170.02%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 5.64M · 30-day average: 7.46M · Max drawdown over stored range: -27.37%

Research Snapshot

Relative Strength vs SPX

RS Composite-2.58%
20D RS4.58%
60D RS-13.18%
120D RS4.43%
Global RS Rank1560 · 53.50% percentile
Qualified+ RS Rank559 · 55.56% percentile
Group ScopeQualified+
Primary RS Rank147 · 67.90% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank93 / 701
Primary Percentile86.88
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-292026-04-2296.36B65.36Bn/a21.04B8.6435.10B7.72B27.38B2,434M67.82%n/a21.83%36.42%28.41%22.05B54.99B

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-29$8.6426.9x$39.595.9x$11.2520.7x$14.4216.1x

Shares Diluted: 2,434M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue7874079990851598882194193
Revenue Growth (YoY)-4.655%1.588%6.462%4.3%6.048%
Gross Profit
Operating Income
Free Cash Flow1975817185182481984219698
Free Cash Flow Per Share7.3889304412864626.4510679830323967.12701140446805158.1674487527784648.108174857989628
EPS (Diluted) GAAP
EPS Growth41.742%-13.828%103.863%-57.799%90.501%
EPS Non-GAAP
Gross Margin70.2794%69.2512%68.8195%69.0715%67.8787%
Operating Margin25.1892%24.9469%24.9028%23.4224%26.8459%
Profit Margin22.6073%20.4651%15.6484%15.8363%28.4565%
Free Cash Flow Margin25.0927%21.4839%21.4282%22.3393%20.9124%
Shares Outstanding (Diluted)26742663.92560.42429.42429.4
Shares Change (YoY)0.124%-0.378%-3.885%-5.116%0.919%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-04-2224.06B66.31%n/an/a5.24B21.76%2.142.45B22.05B54.99Bprocessed
2025 Q42026-02-1124.56B67.56%n/an/a5.12B20.83%2.092.44B20.10B47.93Bprocessed
2025 Q32025-10-2223.99B69.56%n/an/a5.15B21.47%2.122.43B18.56B45.80Bprocessed
2025 Q22025-07-2423.74B67.87%n/an/a5.54B23.32%2.292.42B18.88B50.76Bprocessed
2025 Q12025-04-2321.89B66.40%n/an/a11.00B50.24%4.542.42B38.78B52.25Bprocessed
2024 Q42025-02-1322.52B68.35%n/an/a3.43B15.24%1.412.43B24.52B36.63Bprocessed
2024 Q32024-10-2322.47B69.01%4.48B19.95%2.69B11.99%1.112.43B20.30B35.75Bprocessed
2024 Q22024-07-2522.45B69.40%5.46B24.32%4.69B20.88%1.932.42B25.48B41.49Bprocessed
2024 Q12024-05-0121.38B69.55%4.97B23.24%3.25B15.22%1.342.43B26.22B33.63Bprocessed
2023 Q42024-02-1621.39B68.23%n/an/a4.05B18.92%1.672.43B22.93B29.33Bprocessed
2023 Q32023-10-2721.35B69.06%4.79B22.45%26.03B1.22%10.212.55B23.51B29.92Bprocessed
2023 Q22023-07-3125.53B67.83%860.00M3.37%5.14B20.15%1.962.63B28.50B45.60Bprocessed
2023 Q12023-04-2824.75B66.08%776.00M3.14%-68.00M-0.27%-0.032.61B24.61B52.91Bprocessed
2022 Q32022-10-2723.79B67.19%809.00M3.40%4.46B18.74%1.682.66B34.08B32.03Bprocessed
2022 Q22022-07-2924.02B67.03%784.00M3.26%4.81B20.04%1.802.67B32.57B32.60Bprocessed
2022 Q12022-04-2923.43B67.57%686.00M2.93%5.15B21.98%1.932.67B30.39B33.15Bprocessed
2022 Q42023-02-1623.71B67.24%n/an/a3.52B14.85%1.332.65B23.52B39.66Bprocessed
2021 Q32021-10-2923.34B68.93%-636.00M-2.73%3.67B15.71%1.372.67B31.00B33.93Bprocessed
2021 Q22021-07-2923.31B67.45%804.00M3.45%6.28B26.93%2.352.67B25.31B33.48Bprocessed
2021 Q12021-04-3022.32B68.36%788.00M3.53%6.20B27.76%2.322.67B24.62B33.61Bprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.